Analysts expect AbCellera Biologics Inc. to report revenue of 6.95 M for Q3 26, against a range of 6.72 M to 7.19 M. The most recent reported quarter, Q2 26, came in at 4.05 M, a 50.3% miss against the 8.14 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 6.51 M | 5.10 M | 4.24 M | 17.08 M | 8.96 M | 44.90 M | 8.31 M | 4.05 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 8.46 M | 7.64 M | 7.55 M | 6.31 M | 6.67 M | 6.61 M | 5.47 M | 8.66 M | 7.19 M | 8.17 M | 10.06 M | 10.94 M | 9.50 M | 20.62 M | 6.03 M | 7.31 M | ||||||||||
| Low Estimate | 7.47 M | 7.05 M | 6.46 M | 5.23 M | 5.74 M | 5.99 M | 5.13 M | 7.62 M | 6.72 M | 7.14 M | 8.57 M | 9.45 M | 8.10 M | 17.05 M | 4.96 M | 6.19 M | ||||||||||
| Consensus Estimate | 7.97 M | 7.34 M | 7.01 M | 5.77 M | 6.20 M | 6.30 M | 5.30 M | 8.14 M | 6.95 M | 7.66 M | 9.31 M | 10.20 M | 8.80 M | 18.84 M | 5.50 M | 6.75 M |
Analysts expect AbCellera Biologics Inc. to report earnings per share of -0.18 for Q3 26, against a range of -0.20 to -0.16. The most recent reported quarter, Q2 26, came in at -0.18, a 5.9% miss against the -0.17 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.17 | -0.12 | -0.15 | -0.12 | -0.19 | -0.03 | -0.14 | -0.18 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.11 | -0.13 | -0.13 | -0.13 | -0.13 | -0.13 | -0.16 | -0.15 | -0.16 | -0.17 | -0.18 | -0.19 | -0.19 | -0.16 | -0.19 | -0.20 | ||||||||||
| Low Estimate | -0.13 | -0.15 | -0.15 | -0.15 | -0.15 | -0.15 | -0.20 | -0.19 | -0.20 | -0.19 | -0.22 | -0.21 | -0.23 | -0.18 | -0.21 | -0.22 | ||||||||||
| Consensus Estimate | -0.12 | -0.14 | -0.14 | -0.14 | -0.14 | -0.14 | -0.18 | -0.17 | -0.18 | -0.18 | -0.20 | -0.20 | -0.21 | -0.17 | -0.20 | -0.21 |
Pull Wall Street consensus for AbCellera Biologics Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ABCL&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ABCL", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ABCL&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();